Brief: Sharps Technology, Nephron Pharmaceuticals Signs Distribution Agreement
13/12/2022 13:32
Dec 13 (Reuters) - Sharps Technology Inc STSS.O :
* SHARPS TECHNOLOGY AND NEPHRON PHARMACEUTICALS SIGN
DISTRIBUTION
AGREEMENT FOR ITS INNOVATIVE SYRINGE PRODUCTS
* SHARPS TECHNOLOGY INC - ANTICIPATES PRODUCTS TO BE
AVAILABLE IN
Q1 OF 2023 WITH INITIAL REVENUE FROM THIS AGREEMENT EXPECTED IN
FIRST HALF OF YEAR
Source text for Eikon: ID:nGNXbx7sjy
Further company coverage: STSS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skyai
See all newsBrief: Bastion Trading Asks Skyai Executive Chairman & Directors "Explain Their Roles" In Approving Complete Sol Liquidation & Tender Offer
Brief: SkyAI Formed Special Committee To Review All-Stock Proposal From Forward Industries - SEC Filing
Brief: Forward Industries Says SkyAI Did Not Respond To Proposal By Its Expiration At Close Of Business On June 12
Brief: SkyAI Confirms Receipt Of Unsolicited, Non-Binding Proposal From Forward Industries
Brief: Forward Industries Announces Letter Of Intent To Acquire Skyai, Inc